HomeMRNS • NASDAQ
add
Marinus Pharmaceuticals Inc
Previous close
$1.73
Day range
$1.72 - $1.86
Year range
$1.05 - $11.26
Market cap
101.35M USD
Avg Volume
536.68K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 8.06M | 32.48% |
Operating expense | 18.15M | 5.61% |
Net income | -35.83M | -12.19% |
Net profit margin | -444.74 | 15.31% |
Earnings per share | -0.63 | -3.28% |
EBITDA | -29.10M | 2.45% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 64.68M | -63.11% |
Total assets | 87.08M | -56.72% |
Total liabilities | 134.43M | -6.56% |
Total equity | -47.34M | — |
Shares outstanding | 55.08M | — |
Price to book | -2.01 | — |
Return on assets | -67.47% | — |
Return on capital | -104.70% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -35.83M | -12.19% |
Cash from operations | -30.84M | -26.62% |
Cash from investing | 8.96M | 79.10% |
Cash from financing | -17.70M | -7,567.51% |
Net change in cash | -39.58M | -107.03% |
Free cash flow | -17.15M | -16.98% |
About
Founded
2003
Headquarters
Website
Employees
166